A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium
Phase of Trial: Phase II
Latest Information Update: 17 Sep 2005
At a glance
- Drugs Pemetrexed (Primary)
- Indications Bladder cancer; Urogenital cancer
- Focus Therapeutic Use
- 17 Sep 2005 New trial record.